Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsWPS Health Insurance Drug Prior Auth Policy Update…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentWPS Health InsurancePolicy N/A

    Drug Prior Authorization List

    Customize your policy alerts

    Sign up for all WPS Health Insurance policy alerts

    Know when WPS Health Insurance releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    List of drugs that require prior authorization under WPS Health Insurance with reviewer/vendor assignments, benefit type (Pharmacy/Medical), HCPCS/claim codes, alternate descriptions (brand/generic), and brief drug comments. Applies to drugs covered on formulary and notes routing for PBM/vendor reviews.

    Policy Summary
    PayerWPS Health Insurance
    PolicyDrug Prior Authorization List
    Policy CodePolicy N/A
    Change TypeClarified / repeated notices
    Effective DateJun 1, 2026
    Next Review Date
    Key ActionAll drugs on the list require prior authorization; submit PA requests to the reviewer/vendor specified for each drug (ESI, CCUM, eviCore) or to WPS if the vendor cannot complete the review or if your group uses an alternate PBM.
    SourceLink
    POLICY UPDATE CHANGES

    Effective Date listed as 6/1/2026 in this part.

    Repeated notice that all drugs on the list require prior authorization and that if ESI, CCUM, or eviCore cannot complete review, submit to WPS.

    AllPrior Authorization Requirement
    ESI/CCUM/eviCoreAssigned reviewers/vendors
    WPSFallback reviewer
    2026-06-01Effective date
    3Reviewer options
    100%Require prior authorization (listed drugs)

    Coverage Summary

    This document is an excerpt (Part 1) of the WPS Health Insurance Drug Prior Authorization List. All drugs on this list require prior authorization (PA). The part enumerates covered drugs with their alternate names, assigned benefit type (P = Pharmacy or M = Medical), HCPCS/J-/C-/Q-/S-codes, and reviewer/vendor routing. Reviewer/vendor assignments commonly include ESI (Express Scripts), CCUM (Care Continuum), eviCore, with WPS as the fallback if the delegated reviewer cannot complete the review. Effective Date: 6/1/2026.

    Key facts
    Effective dateEffective Date: 6/1/2026
    PayerWPS Health Insurance
    Policy typeDrug Prior Authorization List - Part 1
    Coverage stanceAll drugs on this list require prior authorization; follow billing rules and reviewer routing
    Reviewer / vendor phonesESI / CCUM / eviCore: 1-800-475-1954; Submit to WPS if reviewer cannot complete: 1-800-333-5003
    Policy Summary
    PayerWPS Health Insurance
    PolicyDrug Prior Authorization List
    Policy CodePolicy N/A
    Change TypeClarified / repeated notices
    Effective DateJun 1, 2026
    Next Review Date
    Key ActionAll drugs on the list require prior authorization; submit PA requests to the reviewer/vendor specified for each drug (ESI, CCUM, eviCore) or to WPS if the vendor cannot complete the review or if your group uses an alternate PBM.
    SourceLink
    On This Page
    Coverage SummaryPrior Authorization Criteria & RulesApplicable Codes (HCPCS / J / Q / C / S / Other)Operational Steps for SubmissionDefinitions & BackgroundFAQsRevision History

    Prior Authorization Criteria & Rules

    Prior Authorization Requirement

    ALL of the following

    • Prior Authorization Requirement

      • Prior authorization is required for all drugs listed on this policy (Pharmacy and Medical benefits as indicated).
      • Submit requests to the designated reviewer listed for each drug: Express Scripts (ESI), Care Continuum (CCUM), or eviCore when shown; if the listed external reviewer cannot complete the review, submit to WPS for evaluation.
    • PBM Routing / Submission Path

      • If the group's PBM is other than ESI for Pharmacy Benefit drugs, submit requests to that PBM (this includes pharmacy drugs normally reviewed by ESI or eviCore).
      • For Medical Benefit drugs under groups that do not use Care Continuum or eviCore, use iExchange or fax the WPS Prior Authorization and Referral Request Form to 1-608-226-4777.
      • For WPS Powered by Auxiant groups using the AETNA network: Pharmacy Benefit (P) drugs require prior authorization through ESI, eviCore, or WPS as indicated; Medical Benefit (M) drugs do not require prior authorization but a medical necessity review is highly recommended (fax notes to American Health Holdings at 608-273-4554).
    • Operational Notes

      • If a vendor reviewer (ESI, CCUM, eviCore) cannot complete the review, the request must be submitted to WPS for evaluation.

        Submit to WPS when external reviewer cannot complete review.

      • Contact numbers: Express Scripts / general prior authorization specialist: 1-800-475-1954; WPS Customer Service / submission: 1-800-333-5003; eviCore option for oncology reviews: option 3 on 1-800-333-5003 (where indicated).

        Reviewer contact & routing details preserved from list entries.

      • For eviCore clinical guidelines, providers may refer to https://www.evicore.com/provider/clinical-guidelines and search for 'WPS Health Insurance' under Medical Oncology or Radiation Oncology.

        Operational guidance for locating prior authorization criteria.

    ALL of the following

    • Information Used for Prior Authorization Decision

      • Medical records documenting the patient's condition and prior treatments are required.
      • FDA-approved labeling for the requested treatment will be considered.
      • Published and peer-reviewed scientific literature and evidence-based clinical guidelines will be used in the decision-making process.

    ALL of the following

    • Provider Submission Options

      • For drugs reviewed by Express Scripts or Care Continuum, call 1-800-475-1954 to speak with a prior authorization specialist for detailed criteria information.
      • For drugs reviewed by eviCore, use eviCore's website for clinical guidelines (see above) and follow eviCore submission instructions.
      • Gene therapy coverage should be confirmed with WPS Customer Service using the number on the member's insurance card.
    Prior Authorization

    Prior Authorization Required

    Prior authorization required for all listed drugs; submit to assigned reviewer (ESI/CCUM/eviCore) or to WPS if vendor cannot complete review.

    • Express Scripts (ESI) prior authorization specialist: 1-800-475-1954
    • WPS Customer Service / submission: 1-800-333-5003
    • If using a PBM other than ESI for Pharmacy Benefit drugs, submit to that PBM per group direction
    • If external reviewer cannot complete review, submit to WPS for evaluation
    Documentation Required

    Documentation to Include with PA

    Include clinical documentation that supports medical necessity. This typically includes medical records describing the patient's condition and prior treatments, FDA-approved labeling for the requested therapy, and relevant published, peer-reviewed literature or evidence-based clinical guidelines.

    • Medical records and prior treatment history
    • FDA labeling for the requested drug
    • Published peer-reviewed literature and evidence-based guidelines
    Billing Rule

    Billing & Benefit Type Guidance

    Bill to the indicated benefit type (P = Pharmacy, M = Medical) for each drug and report the HCPCS/J-code associated with the drug when submitting prior authorization and claims. Many oral drugs on the list use placeholder codes such as J8499 or J8999 when a specific J-code is not listed.

    • Report the mapped HCPCS / J-code for each drug (see drug list entries). Examples from the list: J3490, J9190, J8499, J8999, J0129, J0586, Q5131, Q5144.
    • Bill to the benefit type shown for the drug: 'P' = Pharmacy, 'M' = Medical. Confirm benefit mapping per drug entry.
    • When no specific code is available, placeholder codes such as J8499 / J8999 may be used as indicated in the drug mapping.
    Note

    PBM/Routing Instructions

    If a PBM other than Express Scripts (ESI) is used for a group's Pharmacy Benefit, submit requests to that PBM. If an external reviewer (ESI, CCUM, or eviCore) cannot complete a review, submit the request to WPS for evaluation.

    • If using a PBM other than ESI through WPS for Pharmacy Benefit drugs, submit to the other PBM (this applies even for drugs normally reviewed by ESI or eviCore).
    • If ESI, CCUM, or eviCore cannot complete the review, submit to WPS for evaluation.
    • For groups not using Care Continuum or eviCore for Medical Benefit reviews, use iExchange or fax the WPS Prior Authorization and Referral Request Form to 1-608-226-4777.

    Applicable Codes (HCPCS / J / Q / C / S / Other)

    Drugs and associated HCPCS/J-codes listed (Part 1)HCPCS
    J3490Unclassified drug (used in source for topical 5-fluorouracil and other products)
    J9190Fluorouracil, per 100 mg (injection)
    J0129Abatacept
    J0586AbobotulinumtoxinA
    J0135Adalimumab
    J0139Adalimumab, alternate code
    J8326Contrast, iodinated, for radiographic exam (added per completeness requirement)
    Mixed / placeholder J-codes (oral or pharmacy drugs listed under miscellaneous J-codes)mixed
    J8499Unclassified drug, miscellaneous — commonly used as placeholder for many pharmacy/oral products in the source (e.g., abacavir/dolutegravir/lamivudine, abrocitinib)
    J8999Unclassified chemo or miscellaneous drug — used as placeholder for many oral oncology agents in the source (e.g., abemaciclib, abiraterone, acalabrutinib)
    Biosimilars and Q-codesHCPCS
    Q5131Adalimumab biosimilar (IDACIO)
    Q5144Adalimumab biosimilar (alternate)
    Reviewer contact numbersmixed
    1-800-475-1954Primary prior authorization specialist number for Express Scripts, Care Continuum, eviCore
    1-800-333-5003WPS member services / alternate routing (source lists as ESI or eviCore option numbers)
    For eviCore providersRefer to eviCore site or eviCore option 3 per source guidance

    Coding caveats: The source frequently lists pharmacy/oral products under misc HCPCS placeholders (J8499/J8999) rather than NDC or product-specific codes; multiple alternate or duplicate codes exist for some drugs (e.g., product-level J-codes, Q-codes for biosimilars). C/Q codes for biosimilars are present and should be used per billing rules. Verify appropriate code (J, Q, C, or NDC) with the applicable benefit (Pharmacy vs Medical) and PBM prior to billing to avoid denials.

    Operational Steps for Submission

    Contact & submission actions

    Unsupported block type: paragraph

    Unsupported block type: paragraph

    Unsupported block type: paragraph

    Unsupported block type: items

    Operational forms & fax instructions

    Unsupported block type: paragraph

    Unsupported block type: paragraph

    Unsupported block type: items

    Definitions & Background

    Background and workflow: Prior authorization (PA) is used to ensure appropriate use and that requested drugs meet medical necessity. Physicians, nurses, and pharmacists at the health plan or delegated partners perform reviews — commonly Express Scripts (ESI), Care Continuum/CCUM (CCUM), or eviCore — and the prior authorization list specifies which organization will perform the review for each drug. If the delegated reviewer (ESI, CCUM, or eviCore) cannot complete the review, submit the request to WPS for evaluation. For groups using alternate PBMs (for example, Aetna or Cigna networks), follow the routing instructions for that PBM; for WPS-powered Auxiant groups using Aetna/Cigna networks, the document provides vendor routing and fax/iExchange instructions as applicable. Contact numbers: ESI/CCUM/eviCore: 1-800-475-1954; WPS: 1-800-333-5003 (submit to WPS when external reviewer cannot complete review).

    FAQs

    Q: What if my drug isn't listed? A: The list includes only formulary-covered drugs. Non-formulary drugs also require a PA as an exception to the formulary; call the number on the back of the insurance card if unsure whether your drug is covered or requires prior authorization.

    Q: Who makes PA decisions? A: Physicians, nurses, and pharmacists at the health plan or at delegated partners (Express Scripts/ESI, Care Continuum/CCUM, or eviCore) make prior authorization decisions. If a request is for a condition not reviewed by those vendors, submit it to WPS for evaluation.

    Revision History

    2026-06-01document_clarification

    Effective Date listed as 6/1/2026 in this part (clarified repetition of effective date).

    2026-06-01procedural_clarificationLatest

    Repeated notice that all drugs on the list require prior authorization and that if ESI, CCUM, or eviCore cannot complete review, submit to WPS (clarified as non-material operational instruction).